ST-101 (Spica Therapeutics)

N/A

Report date: 2025/12/16 17:18:09
First In Class

Base Information

Drug NameST-101 (Spica Therapeutics)
Drug Alias NameST101ST-101
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionScavenger receptor cysteine-rich type 1 protein M130 modulators
TargetsScavenger receptor cysteine-rich type 1 protein M130
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgium
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSpica Therapeutics NV
China Registration ClassN/A

Develop Information

Active CompaniesSpica Therapeutics NVProBioGen AG
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A